Search Results 101-110 of 11126 for SC
About this study. The primary objective of the study is to evaluate the effectiveness of depemokimab 200 mg SC every 26 weeks compared with mepolizumab 300 ...
Patrizia Mondello, M.D., Ph.D., M.Sc., a physician-scientist in Mayo Clinic's Department of Hematology, is a recipient of the annual 2023 Gerstner Family ...
Nuttall GA, Voogd SC, Danke H, Warner PA, Oyen LJ, Marienau MS, Ackerman MJ. The incidence of torsades de pointes with peri-operative low-dose ondansetron ...
... SC, Paulson L, Clark-Swanson K, Lassiter-Morris Y, Smith KA, Nakaji P, Bendok BR, Zimmerman RS, Krishna C, Patra DP, Patel NP, Lyons M, Neal M, Donev K ...
IgG4-sclerosing cholangitis (IgG4-SC) can be difficult to distinguish from primary sclerosing cholangitis and cholangiocarcinoma. Dr. Roberts and his ...
... SC, Gamez M, Holtzmann A, Mohammadi H, Garcia J, Chintakuntlawar A, Price KA, Fuentes Bayne HE, Rwigema JCM, Patel SH, McGee LA, Patel S, Janus JR, Chang B ...
Francis Cancer Center in Greenville, SC. Prior to that, he was an Associate Professor of Radiation Oncology at Vanderbilt University Medical Center. During ...
The purpose of this study is to evaluate the clinical benefit of subcutaneous (SC) daratumumab administered in combination with standard multiple myeloma ...
... SC, Jeng BH. Low-Dose Valacyclovir in Herpes Zoster Ophthalmicus: The Zoster Eye Disease Randomized Clinical Trial. JAMA Ophthalmol 2025 Apr 1; 143 (4):269 ...
... SC, Lerman LO. Diabetic Kidney Disease Alters the Transcriptome and Function ... SC, Lerman LO, Herrmann SM. Hypoxic preconditioning induces epigenetic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.